TVTX logo

Travere Therapeutics (TVTX)

Profile

Full Name

Travere Therapeutics, Inc.

Ticker Symbol

TVTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 8, 2012

Indexes

Not included

Website

http://www.travere.com

Employees

385

Key Details

Price

$14.91(+0.54%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$233.18M(+60.55% YoY)

Annual EPS

-$4.08(-172.00% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$14.91
TVTX price is $14.91

30-Day Relative Volume

0.67
TVTX 30-day relative volume is 0.67

Price Performance

Price Most recent change

+0.54%
TVTX price was up +0.54% on Apr 15, 2025

Price YTD change

-14.41%
TVTX price is down -14.41% since January 1st

Price 1-year change

+135.92%
TVTX price is up +135.92% year-on-year

Price 3-year change

-49.7%
TVTX price is down -49.7% over the past 3 years

Price Range

Price All-time high

$37.04
TVTX price is currently -59.75% below its historical high of $37.04

Price 3-year low

$5.12
TVTX price is currently +191.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.32B
TVTX market capitalization is $1.32 billion

Market cap 3-year change

-29.71%
TVTX market capitalization is down -29.71% over the past 3 years

Market cap All-time high

$2.16B
TVTX market capitalization is currently -38.77% below its historical high of $2.16 billion

Market cap sector rank

79.11%
TVTX market capitalization is higher than 79.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16.6%
TVTX shares outstanding is up +16.6% year-on-year

Shares Outstanding 3-Year Change

+39.73%
TVTX shares outstanding is up +39.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
TVTX beta is 1.07

200-day SMA

$15.97
TVTX price is currently -6.61% below its 200-day simple moving average

50-day SMA

$19.59
TVTX price is currently -23.88% below its 50-day simple moving average

RSI

35.79
TVTX 14-day relative strength index is 35.79

Volume

0.67
TVTX 30-day relative volume is 0.67

ATR

$1.31
TVTX average true range is $1.31

10-day Historical Volatility

89.09%
TVTX 10-day historical volatility is 89.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$233.18M
TVTX annual revenue is $233.18 million

Revenue Analysts estimate

$387.54M
TVTX annual revenue is currently -39.83% lower than the consensus analysts' forecast

Revenue 1-year change

+60.55%
TVTX annual revenue is up +60.55% year-on-year

Revenue Sector rank

66.18%
TVTX annual revenue is higher than 66.18% of companies in Healthcare sector

EPS

EPS

-$4.08
TVTX annual earnings per share is -$4.08

EPS Analysts estimate

-$0.39
TVTX annual earnings per share is currently +946.69% higher than the consensus analysts' forecast

EPS 1-year change

-172%
TVTX annual earnings per share is down -172% year-on-year

EPS Sector rank

22.42%
TVTX annual earnings per share is higher than 22.42% of companies in Healthcare sector

Profit

Gross profit

$225.43M
TVTX annual gross profit is $225.43 million

Gross margin

96.68%
TVTX annual gross profit margin is 96.68%

Operating profit

-$321.39M
TVTX annual operating income is -$321.39 million

Operating margin

-137.83%
TVTX annual operating profit margin is -137.83%

Net income

-$321.55M
TVTX annual net profit is -$321.55 million

Net margin

-137.90%
TVTX annual net profit margin is -137.90%

Expenses

Total expenses

$554.56M
TVTX annual total expenses is $554.56 million

Operating expenses

$546.82M
TVTX annual total operating expenses is $546.82 million

Cost of goods sold

$7.74M
TVTX annual cost of goods sold is $7.74 million

Selling, general & administrative expenses

$264.12M
TVTX annual SGA is $264.12 million

Depreciation and amortization

$43.55M
TVTX annual depreciation & amortization is $43.55 million

Interest expense

$11.18M
TVTX annual interest expense is $11.18 million

Income tax

$120.00K
TVTX annual income tax is $120.00 thousand

EBIT & EBITDA

EBIT

-$309.33M
TVTX annual earnings before interest & taxes is -$309.33 million

EBITDA

-$265.77M
TVTX annual EBITDA is -$265.77 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$594.13M
TVTX annual total assets is $594.13 million

Non current assets

$177.47M
TVTX annual long term assets is $177.47 million

Current assets

$416.70M
TVTX annual total current assets is $416.70 million

Cash and cash equivalents

$58.53M
TVTX annual cash & cash equivalents is $58.53 million

Accounts receivable

$27.12M
TVTX annual accounts receivable is $27.12 million

Inventory

$6.20M
TVTX annual inventory is $6.20 million

Liabilities

Total liabilities

$535.05M
TVTX annual total liabilities is $535.05 million

Long term liabilities

$334.30M
TVTX annual total long term liabilities is $334.30 million

Current liabilities

$200.75M
TVTX annual total current liabilities is $200.75 million

Accounts payable

$23.53M
TVTX annual accounts payable is $23.53 million

Debt

Total debt

$401.58M
TVTX annual total debt is $401.58 million

Total debt 1-year change

-0.79%
TVTX annual total debt is down -0.79% year-on-year

Long term debt

$327.50M
TVTX annual long term debt is $327.50 million

Short term debt

$74.08M
TVTX annual short term debt is $74.08 million

Equity & Capital

Shareholders equity

$59.08M
TVTX annual stockholders equity is $59.08 million

Book value

$59.08M
TVTX annual book value is $59.08 million

Retained earnings

-$1.45B
TVTX annual retained earnings is -$1.45 billion

Working capital

$215.95M
TVTX annual working capital is $215.95 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$237.47M
TVTX annual cash flow from operations is -$237.47 million

Cash from operations 1-year change

+15.19%
TVTX annual cash flow from operations is up +15.19% year-on-year

Cash from investing

$99.33M
TVTX annual cash flow from investing activities is $99.33 million

Cash from investing 1-year change

+78.08%
TVTX annual cash flow from investing activities is up +78.08% year-on-year

Cash from financing

$139.42M
TVTX annual cash flow from financing activities is $139.42 million

Cash from financing 1-year change

-36.26%
TVTX annual cash flow from financing activities is down -36.26% year-on-year

CAPEX

CAPEX

$101.21M
TVTX annual capital expenditures is $101.21 million

CAPEX 1-year change

+143.35%
TVTX annual capital expenditures is up +143.35% year-on-year

Free Cash Flow

Free cash flow

-$338.69M
TVTX annual free cash flow is -$338.69 million

Free cash flow 1-year change

-5.31%
TVTX annual free cash flow is down -5.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

96.68%
TVTX annual gross profit margin is 96.68%

Operating margin

-137.83%
TVTX annual operating profit margin is -137.83%

Net margin

-137.90%
TVTX annual net profit margin is -137.90%

ROA & ROE

ROA

-46.50%
TVTX annual return on assets is -46.50%

ROE

-247.45%
TVTX annual return on equity is -247.45%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TVTX price to earnings ratio value is unknown

PE ratio Sector rank

-
TVTX price to earnings ratio is unknown

PB Ratio

PB ratio

22.40
TVTX price to book ratio is 22.40

PB ratio Sector rank

96.95%
TVTX price to book ratio is higher than 96.95% of companies in Healthcare sector

PS Ratio

PS ratio

5.67
TVTX price to sales ratio is 5.67

PS ratio Sector rank

68.72%
TVTX price to sales ratio is higher than 68.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.67B
TVTX enterprise value is $1.67 billion

Enterprise value Sector rank

80.17%
TVTX enterprise value is higher than 80.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-6.27
TVTX EV/EBITDA is -6.27

EV/EBITDA Sector rank

16.09%
TVTX EV/EBITDA is higher than 16.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.08
TVTX annual current ratio is 2.08

Quick ratio

2.04
TVTX annual quick ratio is 2.04

Leverage

Debt to equity

6.42
TVTX annual debt to equity ratio is 6.42

Interest coverage ratio

-27.66
TVTX annual interest coverage ratio is -27.66

Risk & Stability

Piotroski F-Score

4
TVTX piotroski f-score is 4

Altman Z-Score

-2.82
TVTX altman z-score is -2.82

Analyst ratings

Recent major analysts updates

Apr 10, 25 Canaccord Genuity
Buy
Apr 3, 25 Cantor Fitzgerald
Overweight
Apr 1, 25 B of A Securities
Buy
Feb 26, 25 JP Morgan
Overweight
Feb 24, 25 Citigroup
Buy
Feb 21, 25 Cantor Fitzgerald
Overweight
Feb 12, 25 Scotiabank
Sector Outperform
Feb 12, 25 Evercore ISI Group
Outperform
Feb 12, 25 Canaccord Genuity
Buy
Jan 15, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IMCR logo
Immunocore Holdings (IMCR)
MESO logo
Mesoblast Limited (MESO)
VERA logo
Vera Therapeutics (VERA)
TDOC logo
Teladoc Health (TDOC)
BKD logo
Brookdale Senior Living (BKD)
IART logo
Integra LifeSciences Holdings (IART)
EWTX logo
Edgewise Therapeutics (EWTX)
PHR logo
Phreesia (PHR)
MNKD logo
MannKind (MNKD)
  • What is the ticker symbol for Travere Therapeutics?
  • Does Travere Therapeutics pay dividends?
  • What sector is Travere Therapeutics in?
  • What industry is Travere Therapeutics in?
  • What country is Travere Therapeutics based in?
  • When did Travere Therapeutics go public?
  • Is Travere Therapeutics in the S&P 500?
  • Is Travere Therapeutics in the NASDAQ 100?
  • Is Travere Therapeutics in the Dow Jones?
  • When was Travere Therapeutics's last earnings report?
  • When does Travere Therapeutics report earnings?
  • Should I buy Travere Therapeutics stock now?

What is the ticker symbol for Travere Therapeutics?

The ticker symbol for Travere Therapeutics is NASDAQ:TVTX

Does Travere Therapeutics pay dividends?

No, Travere Therapeutics does not pay dividends

What sector is Travere Therapeutics in?

Travere Therapeutics is in the Healthcare sector

What industry is Travere Therapeutics in?

Travere Therapeutics is in the Biotechnology industry

What country is Travere Therapeutics based in?

Travere Therapeutics is headquartered in United States

When did Travere Therapeutics go public?

Travere Therapeutics's initial public offering (IPO) was on November 8, 2012

Is Travere Therapeutics in the S&P 500?

No, Travere Therapeutics is not included in the S&P 500 index

Is Travere Therapeutics in the NASDAQ 100?

No, Travere Therapeutics is not included in the NASDAQ 100 index

Is Travere Therapeutics in the Dow Jones?

No, Travere Therapeutics is not included in the Dow Jones index

When was Travere Therapeutics's last earnings report?

Travere Therapeutics's most recent earnings report was on Feb 20, 2025

When does Travere Therapeutics report earnings?

The next expected earnings date for Travere Therapeutics is May 6, 2025

Should I buy Travere Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page